Skip to main content

Advertisement

Table 1 Detection rates of the GynTect assay for the sample cohort in PreservCyt (Hologic)

From: Performance of a DNA methylation marker panel using liquid-based cervical scrapes to detect cervical cancer and its precancerous stages

All ages CxCa (n = 5) CIN3 (n = 50) CIN2 (n = 19) CIN1 (n = 5) NILM (n = 201)
# tested samples 5 50 19 5 201
# GynTect positive 5 30 8 1 3
# GynTect negative 0 19 10 4 196
# GynTect invalid 0 1 1 0 2
# valid samples 5 49 18 5 199
detection rate [%] 100.0% 61.2% 44.4% 20.0% 1.5%